DECADRON Side Effects

7028072-9 | Malignant Neoplasm Progression, Pleural Mesothelioma Malignant Advanced, Pneumonia, Weight Decreased
on Sep 20, 2010 Male patient from AUSTRALIA , 59 years of age, was diagnosed with nausea (What is nausea?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, pleural mesothelioma malignant advanced, pneumonia (What is pneumonia?), weight decreased. Decadron dosage: 4 Mg/prn Po. During the same period patient was treated with MAXOLON (10 Mg/prn Po) (View Maxolon Review and Maxolon Label ). Patient was hospitalized.

7026581-X | Apnoea, Blood Glucose Increased, Blood Ph Decreased, Cerebral Haemorrhage, Cranial Nerve Disorder, Disease Progression, Dysphagia, Dyspnoea
Patient was taking Decadron (View Usage). Patient had the following side effects: apnoea, blood glucose increased, blood ph decreased, cerebral haemorrhage, cranial nerve disorder, disease progression, dysphagia, dyspnoea on Sep 27, 2010 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, was diagnosed with glioblastoma multiforme and. Decadron dosage: Po. During the same period patient was treated with SUTENT (15 Mg/m[2]/daily/po) (View Sutent Review and Sutent Label ). Patient was hospitalized.

7024348-X | Abasia, Adrenal Insufficiency, Agitation, Anaemia Macrocytic, Aphasia, Blood Calcium Increased, Brain Injury, Confusional State, Dehydration
Adverse event was reported on Sep 11, 2010 by a Female patient taking Decadron (View Usage) (Dosage: Po) was diagnosed with metastases to central nervous system, prophylaxis, myositis (What is myositis?), radiation associated pain and. Location: UNITED STATES , 67 years of age, weighting 139.0 lb, After Decadron was administered, patient had the following side effects: abasia, adrenal insufficiency, agitation, anaemia macrocytic, aphasia (What is aphasia?), blood calcium increased, brain injury, confusional state, dehydration. During the same period patient was treated with NEURONTIN (900 Mg/tid) (View Neurontin Review and Neurontin Label ), MS CONTIN (30 Mg/tid) (View Ms Contin Review and Ms Contin Label ), OXYCODONE HCL (5 To 10 Mg Q2h Mg/prn/po) (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

7007152-8 | Blood Pressure Decreased, Myocardial Ischaemia, Sepsis
on Aug 30, 2010 Male patient from AUSTRALIA , 65 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, myocardial ischaemia, sepsis (What is sepsis?). Decadron dosage: 20 Mg Daily, Po. During the same period patient was treated with CAP VORINOSTAT (400 Mg/daily Po) (View Cap Vorinostat Review and Cap Vorinostat Label ), VELCADE (1.25 Mg/daily) (View Velcade Review and Velcade Label ), ENDEP (View Endep Review and Endep Label ), ENDONE (View Endone Review and Endone Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), NULYTELY (View Nulytely Review and Nulytely Label ). Patient was hospitalized.


7006454-9 | Zygomycosis
on Sep 15, 2010 Male patient from JAPAN , 67 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), bronchopulmonary aspergillosis and was treated with Decadron (View Usage). Patient had the following side effects: zygomycosis. Decadron dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), FUNGUARD (View Funguard Review and Funguard Label ), VFEND (View Vfend Review and Vfend Label ).

6977560-X | Angina Pectoris, Hyperglycaemia, Ischaemia
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: angina pectoris, hyperglycaemia, ischaemia on Aug 31, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 60 years of age, was diagnosed with rectal cancer and. Decadron dosage: . During the same period patient was treated with TEGAFUR AND URACIL (View Tegafur And Uracil Review and Tegafur And Uracil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), DOTHIEPIN HYDROCHLORIDE (View Dothiepin Hydrochloride Review and Dothiepin Hydrochloride Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6973696-8 | Myocardial Ischaemia, Sepsis
Adverse event was reported on Aug 25, 2010 by a Male patient taking Decadron (View Usage) (Dosage: 20 Mg/daily/po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: AUSTRALIA , 65 years of age, Patient experienced the following unwanted or unexpected effects: myocardial ischaemia, sepsis (What is sepsis?). During the same period patient was treated with CAP VORINOSTAT (400 Mg/daily/po) (View Cap Vorinostat Review and Cap Vorinostat Label ), VELCADE (1.25 Mg/daily/iv) (View Velcade Review and Velcade Label ), ENDEP (View Endep Review and Endep Label ), ENDONE (View Endone Review and Endone Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), NULYTELY (View Nulytely Review and Nulytely Label ). Patient was hospitalized.

6963560-2 | Red Blood Cells Urine Positive, Sepsis, Urinary Sediment Present, White Blood Cells Urine Positive
on Aug 20, 2010 Male patient from AUSTRALIA , 65 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient had the following side effects: red blood cells urine positive, sepsis (What is sepsis?), urinary sediment present, white blood cells urine positive. Decadron dosage: 20 Mg/daily, Po. During the same period patient was treated with CAP VORINOSTAT (400 Mg/daily, Po) (View Cap Vorinostat Review and Cap Vorinostat Label ), VELCADE (1.25 Mg/daily, Iv) (View Velcade Review and Velcade Label ), ENDEP (View Endep Review and Endep Label ), ENDONE (View Endone Review and Endone Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), NULYTELY (View Nulytely Review and Nulytely Label ). Patient was hospitalized.

6945631-X | Acute Respiratory Failure, Anaemia, Asthenia, Back Pain, Bronchitis, Dehydration, Diarrhoea, Myopathy, Nausea
on Aug 23, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: acute respiratory failure, anaemia, asthenia, back pain (What is back pain?), bronchitis (What is bronchitis?), dehydration, diarrhoea, myopathy, nausea (What is nausea?). Decadron dosage: . During the same period patient was treated with THALOMID (View Thalomid Review and Thalomid Label ), VELCADE (Day 1, 4, 8 And 11) (View Velcade Review and Velcade Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VICODIN (View Vicodin Review and Vicodin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6940875-5 | Cellulitis, Liver Function Test Abnormal, Oedema Peripheral
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), liver function test abnormal, oedema peripheral on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with back pain (What is back pain?) and. Decadron dosage: . During the same period patient was treated with EVISTA (View Evista Review and Evista Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HYDROCHLORIDE (View Quinapril Hydrochloride Review and Quinapril Hydrochloride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6932493-X | Oedema Peripheral, Post Procedural Infection
Adverse event was reported on Aug 17, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 59 years of age, Patient had the following side effects: oedema peripheral, post procedural infection. During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6929149-6 | Dizziness, Hypertension, Pneumonia
on Aug 12, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?). Decadron dosage: . During the same period patient was treated with THALOMID (View Thalomid Review and Thalomid Label ), COREG (View Coreg Review and Coreg Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

6925579-7 | Shock
on Aug 04, 2010 Female patient from JAPAN , 65 years of age, weighting 97.00 lb, was diagnosed with ovarian cancer and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: shock. Decadron dosage: . During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), AMINO ACID INJ (Daily Dosage Unknwon) (View Amino Acid Inj Review and Amino Acid Inj Label ), DEXTROSE (Daily Dosage Unknwon) (View Dextrose Review and Dextrose Label ), MINERALIN (View Mineralin Review and Mineralin Label ), SODIUM CHLORIDE (Daily Dosage Unknwon) (View Sodium Chloride Review and Sodium Chloride Label ).

6919598-4 | Threatened Labour
Patient was taking Decadron (View Usage). Patient had the following side effects: threatened labour on Aug 04, 2010 from JAPAN Additional patient health information: Female patient , 27 years of age, was diagnosed with tocolysis and. Decadron dosage: 6.0 Mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

6919592-3 | Premature Baby
Adverse event was reported on Aug 04, 2010 by a Female patient taking Decadron (View Usage) (Dosage: 6.0mg X 4/2 Days) was diagnosed with tocolysis and. Location: JAPAN , weighting 4.41 lb, After Decadron was administered, patient had the following side effects: premature baby. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6919591-1 | Premature Baby
on Aug 04, 2010 Female patient from JAPAN , weighting 4.41 lb, was diagnosed with tocolysis and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby. Decadron dosage: 6.0mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6917722-0 | Haemoglobin Decreased, Melaena
on Aug 03, 2010 Male patient from CANADA , 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Decadron (View Usage). Patient had the following side effects: haemoglobin decreased, melaena. Decadron dosage: 4 Mg/bid/po. During the same period patient was treated with IMC 11F8 (NECITUMUMAB) (600 Mg/iv ) (View Imc-11f8 (necitumumab) Review and Imc-11f8 (necitumumab) Label ), PEMETREXED DISODIUM (893 Mg/q3w/iv ) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), CISPLATIN (133 Mg/q3w/iv) (View Cisplatin Review and Cisplatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6917713-X | Arthralgia, Back Pain, Chest Pain, Cough, Decreased Appetite, Dyspnoea, Hyperhidrosis, Malignant Neoplasm Progression, Mesothelioma
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: arthralgia, back pain (What is back pain?), chest pain (What is chest pain?), cough, decreased appetite, dyspnoea, hyperhidrosis, malignant neoplasm progression, mesothelioma (What is mesothelioma?) on Jul 30, 2010 from AUSTRALIA Additional patient health information: Male patient , 59 years of age, was diagnosed with nausea (What is nausea?) and. Decadron dosage: 4 Mg/prn/po . During the same period patient was treated with MAXOLON (10 Mg/prn/po) (View Maxolon Review and Maxolon Label ), ZOFRAN (4 Mg/prn /po) (View Zofran Review and Zofran Label ). Patient was hospitalized.

6917263-0 | Acute Myocardial Infarction, Myocardial Ischaemia
Adverse event was reported on Aug 03, 2010 by a Female patient taking Decadron (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 79 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, myocardial ischaemia. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ). Patient was hospitalized.

6911161-4 | Angina Pectoris, Myocardial Infarction
on Mar 09, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient had the following side effects: angina pectoris, myocardial infarction. Decadron dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6911126-2 | Threatened Labour
on Aug 02, 2010 Female patient from JAPAN , 27 years of age, was diagnosed with tocolysis and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: threatened labour. Decadron dosage: 6.0 Mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

6911121-3 | Premature Baby
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby on Aug 02, 2010 from JAPAN Additional patient health information: Female patient , weighting 4.41 lb, was diagnosed with tocolysis and. Decadron dosage: 6.0mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6911118-3 | Premature Baby
Adverse event was reported on Aug 02, 2010 by a Female patient taking Decadron (View Usage) (Dosage: 6.0mg X 4/2 Days) was diagnosed with tocolysis and. Location: JAPAN , weighting 4.41 lb, Patient had the following side effects: premature baby. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6907346-3 | Abdominal Discomfort, Blood Corticotrophin Increased, Blood Cortisol Abnormal, Convulsion, Fatigue, Glucocorticoids Decreased, Nausea, Skin Hyperpigmentation
on Jul 19, 2010 Male patient from UNITED KINGDOM , 14 years of age, was diagnosed with temporal lobe epilepsy, glucocorticoids decreased and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: abdominal discomfort, blood corticotrophin increased, blood cortisol abnormal, convulsion, fatigue, glucocorticoids decreased, nausea (What is nausea?), skin hyperpigmentation. Decadron dosage: 1 Mg/daily; Po. During the same period patient was treated with OXCARBAZEPINE (1800 Mg/daily; Po, 2400 Mg/daily; Po, 600 Mg/daily; Po) (View Oxcarbazepine Review and Oxcarbazepine Label ), HYDROCORTONE (Unk; Po) (View Hydrocortone Review and Hydrocortone Label ), PRASTERONE (Unk; Po) (View Prasterone Review and Prasterone Label ).

6907328-1 | Atelectasis, Blood Pressure Diastolic Decreased, Body Temperature Increased, Haematocrit Decreased, Haemoglobin Decreased, International Normalised Ratio Increased, Lymphadenopathy, Mobility Decreased, Platelet Count Decreased
on Jul 27, 2010 Female patient from UNITED STATES , 58 years of age, weighting 196.0 lb, was diagnosed with prophylaxis and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, blood pressure diastolic decreased, body temperature increased, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, lymphadenopathy, mobility decreased, platelet count decreased. Decadron dosage: 4 Mg/bid/po`. During the same period patient was treated with MS CONTIN UNK (45 Mg/bid/po) (View Ms Contin Unk Review and Ms Contin Unk Label ), REMERON (50 Mg/prn/po) (View Remeron Review and Remeron Label ), DILANTIN (View Dilantin Review and Dilantin Label ), KEPPRA (1500 Mg/bid/po) (View Keppra Review and Keppra Label ), ADVAIR HFA (/prn/inh Inhl) (View Advair Hfa Review and Advair Hfa Label ), ALBUTEROL (/tid/inh) (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6883493-X | Threatened Labour
Patient was taking Decadron (View Usage). Patient had the following side effects: threatened labour on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 27 years of age, was diagnosed with tocolysis and. Decadron dosage: 6.0 Mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

6883477-1 | Premature Baby
Adverse event was reported on Jul 21, 2010 by a Female patient taking Decadron (View Usage) (Dosage: 6.0mg X 4/2 Days) was diagnosed with tocolysis and. Location: JAPAN , weighting 4.41 lb, After Decadron was administered, patient had the following side effects: premature baby. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6883475-8 | Premature Baby
on Jul 21, 2010 Female patient from JAPAN , weighting 4.41 lb, was diagnosed with tocolysis and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby. Decadron dosage: 6.0mg X 4/2 Days. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6863054-9 | Hyperglycaemia, Loss Of Consciousness
on Jul 14, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient had the following side effects: hyperglycaemia, loss of consciousness. Decadron dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CRESTOR (View Crestor Review and Crestor Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6862708-8 | Abdominal Discomfort, Blood Corticotrophin Increased, Blood Cortisol Abnormal, Convulsion, Fatigue, Glucocorticoids Decreased, Nausea, Skin Hyperpigmentation
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: abdominal discomfort, blood corticotrophin increased, blood cortisol abnormal, convulsion, fatigue, glucocorticoids decreased, nausea (What is nausea?), skin hyperpigmentation on Jul 01, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 14 years of age, was diagnosed with temporal lobe epilepsy and. Decadron dosage: 1 Mg/daily, Po. During the same period patient was treated with OXCARBAZEPINE (1800 Mg/daily, Po; 2400 Mg/daily, Po; 600 Mg/daily, Po) (View Oxcarbazepine Review and Oxcarbazepine Label ).

6847397-0 | Deep Vein Thrombosis, Pulmonary Embolism
Adverse event was reported on Jun 16, 2010 by a Female patient taking Decadron (View Usage) (Dosage: Po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with THALIDOMIDE (Po) (View Thalidomide Review and Thalidomide Label ).

6836330-3 | Gastrointestinal Haemorrhage, Melaena, Nausea
on Jun 18, 2010 Female patient from UNITED KINGDOM , 60 years of age, was diagnosed with metastatic neoplasm, bone pain and was treated with Decadron (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, melaena, nausea (What is nausea?). Decadron dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NULYTELY (View Nulytely Review and Nulytely Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ORAMORPH SR (View Oramorph Sr Review and Oramorph Sr Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6827044-4 | Hallucinations, Mixed, Narcotic Intoxication
on Jun 25, 2010 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with metastasis, pain (What is pain?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: hallucinations, mixed, narcotic intoxication. Decadron dosage: . During the same period patient was treated with MST UNICONTINUS (View Mst Unicontinus Review and Mst Unicontinus Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SERETIDE (View Seretide Review and Seretide Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6820181-X | Completed Suicide, Depressive Symptom
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, depressive symptom on Jun 28, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer (What is breast cancer?) and. Decadron dosage: . During the same period patient was treated with GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ).

6820138-9 | Colon Cancer, Diabetic Ketoacidosis, Nausea
Adverse event was reported on Jun 30, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with nausea (What is nausea?) and. Location: JAPAN , 76 years of age, Patient had the following side effects: colon cancer, diabetic ketoacidosis, nausea (What is nausea?). During the same period patient was treated with DEXART (View Dexart Review and Dexart Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6818841-X | Deep Vein Thrombosis, Pulmonary Embolism
on Jun 16, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Decadron dosage: Po. During the same period patient was treated with CAP THALIDOMIDE (Po) (View Cap Thalidomide Review and Cap Thalidomide Label ).

6817850-4 | Phaeochromocytoma Crisis
on Jun 28, 2010 Male patient from JAPAN , 53 years of age, weighting 121.3 lb, was diagnosed with cushing's syndrome, diabetes mellitus, hypertension and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: phaeochromocytoma crisis. Decadron dosage: . During the same period patient was treated with NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), NOVORAPID (10-8-8) (View Novorapid Review and Novorapid Label ), LEVEMIR (View Levemir Review and Levemir Label ).

6816447-X | Alopecia, Constipation, Disease Progression, Dizziness, Dyspnoea, Fatigue, Haemoglobin Decreased, Hyperglycaemia, Hypertension
Patient was taking Decadron (View Usage). Patient had the following side effects: alopecia, constipation (What is constipation?), disease progression, dizziness (What is dizziness?), dyspnoea, fatigue, haemoglobin decreased, hyperglycaemia, hypertension on Jun 16, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Decadron dosage: Po. During the same period patient was treated with SODIUM PHOSPHATES (View Sodium Phosphates Review and Sodium Phosphates Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), ASPARAGUS (View Asparagus Review and Asparagus Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MK 2206 (View Mk-2206 Review and Mk-2206 Label ).

6803548-5 | Cerebellar Infarction
Adverse event was reported on Jun 18, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 67 years of age, After Decadron was administered, patient had the following side effects: cerebellar infarction. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), ADRIACIN (View Adriacin Review and Adriacin Label ).

6799162-0 | Anaemia, Asthenia, Confusional State, Fatigue, Metastases To Central Nervous System, Post Procedural Haematoma, Pulmonary Embolism, Somnolence
on Jun 01, 2010 Female patient from UNITED STATES , 45 years of age, weighting 169.0 lb, was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, confusional state, fatigue, metastases to central nervous system, post procedural haematoma, pulmonary embolism (What is pulmonary embolism?), somnolence. Decadron dosage: See Image. Patient was hospitalized.

6782141-7 | Myoclonus
on Jun 10, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Decadron (View Usage). Patient had the following side effects: myoclonus. Decadron dosage: . During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6768813-9 | Abnormal Behaviour, Agitation, Anxiety, Bone Graft Lysis, Brain Abscess, Depression, Fluctuance, Meningeal Disorder, Mental Disorder
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: abnormal behaviour, agitation, anxiety (What is anxiety?), bone graft lysis, brain abscess, depression (What is depression?), fluctuance, meningeal disorder, mental disorder on Jun 04, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, weighting 220.0 lb, was diagnosed with brain oedema, glioblastoma and. Decadron dosage: 4 Mg/bid/po. During the same period patient was treated with CAP MK 0752 UNK (3200 Mg/wky/po) (View Cap Mk-0752 Unk Review and Cap Mk-0752 Unk Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ZONEGRAN (View Zonegran Review and Zonegran Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ). Patient was hospitalized.

6768212-X | Anaemia, Candidiasis, Hypocalcaemia, Hypomagnesaemia, Pancytopenia, Pneumonia, Renal Failure Acute, Vitamin D Deficiency
Adverse event was reported on May 17, 2010 by a Male patient taking Decadron (View Usage) (Dosage: 4mg Daily (20 Mg Every Monday)) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 58 years of age, weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: anaemia, candidiasis, hypocalcaemia, hypomagnesaemia, pancytopenia, pneumonia (What is pneumonia?), renal failure acute, vitamin d deficiency. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), LORTAB (View Lortab Review and Lortab Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VELCADE (View Velcade Review and Velcade Label ), REVLIMID (Daily X 21 Days And 7 Days Off) (View Revlimid Review and Revlimid Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6767034-3 | Diabetic Ketoacidosis
on Jun 02, 2010 Female patient from JAPAN , 49 years of age, weighting 99.21 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Decadron (View Usage). Patient had the following side effects: diabetic ketoacidosis. Decadron dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6764295-1 | Ophthalmoplegia
on Jun 04, 2010 Male patient from SPAIN , 50 years of age, was diagnosed with neoplasm progression, status epilepticus and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: ophthalmoplegia. Decadron dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CISPLATIN AND FLUOROURACIL (View Cisplatin And Fluorouracil Review and Cisplatin And Fluorouracil Label ).

6745980-4 | Pulmonary Embolism
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 196.0 lb, . Decadron dosage: Po. Patient was hospitalized.

6740283-6 | Decreased Appetite, Dehydration, Fatigue, Nausea, Renal Failure
Adverse event was reported on May 20, 2010 by a Female patient taking Decadron (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), hyperlipidaemia, hypothyroidism, vomiting, nausea (What is nausea?) and. Location: UNITED STATES , 60 years of age, Patient had the following side effects: decreased appetite, dehydration, fatigue, nausea (What is nausea?), renal failure. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), REVLIMID (Daily X 21 Days, Off 7 Days) (View Revlimid Review and Revlimid Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), COMPAZINE (View Compazine Review and Compazine Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized and became disabled.

6739247-8 | Dizziness, Fatigue, Headache, Hot Flush, Intra-abdominal Pressure Increased, Muscular Weakness, Nausea, Tremor, Vascular Rupture
on May 24, 2010 Female patient from UNITED STATES , 38 years of age, weighting 168.0 lb, was diagnosed with rash (What is rash?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, headache (What is headache?), hot flush, intra-abdominal pressure increased, muscular weakness, nausea (What is nausea?), tremor, vascular rupture. Decadron dosage: 8mg Tapered To 1mg Daily For 14 Days Po.

6736442-9 | Aggression, Agitation, Insomnia, Irritability
on May 05, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, agitation, insomnia, irritability. Decadron dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6734098-2 | Cholelithiasis, Pancreatitis, Pruritus, Rash
Patient was taking Decadron (View Usage). Patient had the following side effects: cholelithiasis, pancreatitis, pruritus, rash (What is rash?) on May 17, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Decadron dosage: . During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), REVLIMID (Daily For 21 Days Every 28 Days) (View Revlimid Review and Revlimid Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.